View in EDS HTML Full Text PDF Full Text

Pembrolizumab with Carboplatin and Paclitaxel Versus Alternative Systemic Treatments Recommended for the First-Line Treatment of Recurrent/Metastatic Head and Neck Cancer: An Indirect Treatment Comparison.

Saved in:
Bibliographic Details
Title: Pembrolizumab with Carboplatin and Paclitaxel Versus Alternative Systemic Treatments Recommended for the First-Line Treatment of Recurrent/Metastatic Head and Neck Cancer: An Indirect Treatment Comparison.
Authors: Dzienis M; Cancer Department, Gold Coast University Hospital, Southport, QLD, Australia., Mojebi A; Evidence Synthesis, Precision AQ, Vancouver, BC, Canada., Keeping S; Evidence Synthesis, Precision AQ, Vancouver, BC, Canada., Black CM; Value and Implementation, Outcomes Research, Merck & Co., Inc., Rahway, NJ, USA., Giezek H; Biostatistics and Research Decision Sciences, Health Technology Assessment, MSD, Brussels, Belgium., Naicker N; Oncology European Clinical Development, MSD (UK) Limited, London, UK., Vanetta C; Biostatistics and Research Decision Sciences, Health Technology Assessment, MSD, Zurich, Switzerland., Park JE; Evidence Synthesis, Precision AQ, Vancouver, BC, Canada., Chan K; Evidence Synthesis, Precision AQ, Vancouver, BC, Canada., Merchant S; Value and Implementation, Outcomes Research, Merck & Co., Inc., Rahway, NJ, USA., Zheng D; Value and Implementation, Outcomes Research, Merck & Co., Inc., Rahway, NJ, USA. dandan.zheng@merck.com.
Source: Advances in therapy [Adv Ther] 2025 Jun; Vol. 42 (6), pp. 2690-2707. Date of Electronic Publication: 2025 Apr 24.
Publication Type: Comparative Study; Journal Article; Network Meta-Analysis; Systematic Review
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40272712
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pembrolizumab with Carboplatin and Paclitaxel Versus Alternative Systemic Treatments Recommended for the First-Line Treatment of Recurrent/Metastatic Head and Neck Cancer: An Indirect Treatment Comparison.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dzienis+M%22">Dzienis M</searchLink>; Cancer Department, Gold Coast University Hospital, Southport, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Mojebi+A%22">Mojebi A</searchLink>; Evidence Synthesis, Precision AQ, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Keeping+S%22">Keeping S</searchLink>; Evidence Synthesis, Precision AQ, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Black+CM%22">Black CM</searchLink>; Value and Implementation, Outcomes Research, Merck & Co., Inc., Rahway, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Giezek+H%22">Giezek H</searchLink>; Biostatistics and Research Decision Sciences, Health Technology Assessment, MSD, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Naicker+N%22">Naicker N</searchLink>; Oncology European Clinical Development, MSD (UK) Limited, London, UK.<br /><searchLink fieldCode="AU" term="%22Vanetta+C%22">Vanetta C</searchLink>; Biostatistics and Research Decision Sciences, Health Technology Assessment, MSD, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Park+JE%22">Park JE</searchLink>; Evidence Synthesis, Precision AQ, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Chan+K%22">Chan K</searchLink>; Evidence Synthesis, Precision AQ, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Merchant+S%22">Merchant S</searchLink>; Value and Implementation, Outcomes Research, Merck & Co., Inc., Rahway, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Zheng+D%22">Zheng D</searchLink>; Value and Implementation, Outcomes Research, Merck & Co., Inc., Rahway, NJ, USA. dandan.zheng@merck.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2025 Jun; Vol. 42 (6), pp. 2690-2707. <i>Date of Electronic Publication: </i>2025 Apr 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Comparative Study; Journal Article; Network Meta-Analysis; Systematic Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40272712
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-025-03144-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2690
    Titles:
      – TitleFull: Pembrolizumab with Carboplatin and Paclitaxel Versus Alternative Systemic Treatments Recommended for the First-Line Treatment of Recurrent/Metastatic Head and Neck Cancer: An Indirect Treatment Comparison.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dzienis M
      – PersonEntity:
          Name:
            NameFull: Mojebi A
      – PersonEntity:
          Name:
            NameFull: Keeping S
      – PersonEntity:
          Name:
            NameFull: Black CM
      – PersonEntity:
          Name:
            NameFull: Giezek H
      – PersonEntity:
          Name:
            NameFull: Naicker N
      – PersonEntity:
          Name:
            NameFull: Vanetta C
      – PersonEntity:
          Name:
            NameFull: Park JE
      – PersonEntity:
          Name:
            NameFull: Chan K
      – PersonEntity:
          Name:
            NameFull: Merchant S
      – PersonEntity:
          Name:
            NameFull: Zheng D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1